Navigation Links
Inhaled nitric oxide therapy does not reduce death risk of infants

Premature infants with lung problem are often treated with inhaled nitric oxide// therapy. A recent study had brought out the fact that this therapy does not reduce the chances of death or further lung infections.

Researchers for the study are of opinion that premature babies who weigh less than 1.5kgs need not be given inhaled nitric oxide therapy unless they are the part of a study. Inhaled nitric oxide therapy is effective for treating lung infections in babies who are born after a full term pregnancy. This treatment makes the blood vessels in the body more effective in absorbing the oxygen for the metabolism.

Researchers who had conducted the study on 420 pre-term infants with lung infection found that there does not exist any significant difference between those infants who had received the therapy and those who were given a placebo. 60 % of the infants in the first group and 68% of infants in the placebo group had developed the serious lung infection of bronchopulmonary dysplasia. The death rate was also high in both groups, with 52% of the infants with inhaled nitric oxide and 48% of the infants with placebo failing to survive.

Reference: National Institutes of Health, Press release, July 2005
'"/>




Page: 1

Related medicine news :

1. Inhaled Steroids Safe & Effective for Children with Asthma
2. Inhaled Corticosteroids Found To Have No Significant Effect On COPD
3. The Effectiveness Of Inhaled Corticosteroids Studied
4. The Effectiveness Of Inhaled Corticosteroids Studied
5. New Drug Exubera (Oral Inhaled Insulin) To Be Monitored By Pfizer
6. HIIP- A Novel Inhaled Insulin Delivery System As An Alternative To Injectable Insulin Therapy
7. Inhaled Insulin To Be Made Available in India
8. Inhaled Insulin Could Rock The Drug Market Soon
9. High Cost Forces NHS To Reject Inhaled Insulin
10. Inhaled Cyclosporine Results In Rejection Free Survival among Lung Transplant Patients
11. Inhaled Insulin: A New Modality for Management of Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
(Date:10/12/2017)... WILMINGTON, Del. (PRWEB) , ... October 12, 2017 ... ... technology and advisory services for healthcare compliance program management, will showcase a range ... and National Association for Assisted Living (NCAL) Convention and Expo to be held ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company ... of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every ... meet the highest standard. , These products are also: Gluten Free, Non-GMO, ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... AccentCare, a leader in post-acute health care, have expanded their existing home health ... Home Health. , AccentCare has been operating a joint venture home health company ...
(Date:10/12/2017)... ... 2017 , ... HMP , a leader in healthcare events and education, today ... Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & ... award competition recognizes editorial and design excellence across a range of sectors. This year’s ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Oct. 2, 2017  AllianceRx Walgreens Prime, the combined ... Walgreens and pharmacy benefit manager Prime Therapeutics LLC (Prime), ... which included the unveiling of new signage at its ... well as at a few other company-owned facilities across ... to patients, some of whom will begin to see ...
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans ... advance the use of wearable and home sensors for ... disorders. Early Signal Foundation, a nonprofit organization focused on ... will provide an affordable analytical system to record and ... ...
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
Breaking Medicine Technology: